SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-22-000118
Filing Date
2022-12-01
Accepted
2022-11-30 18:27:36
Documents
15
Period of Report
2022-11-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lumo-20221129.htm   iXBRL 8-K 32562
2 EX-99.1 lumo-20221129x8kxex991.htm EX-99.1 12969
7 image_0a.jpg GRAPHIC 5395
  Complete submission text file 0001126234-22-000118.txt   225313

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lumo-20221129.xsd EX-101.SCH 2250
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lumo-20221129_def.xml EX-101.DEF 15000
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lumo-20221129_lab.xml EX-101.LAB 29064
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lumo-20221129_pre.xml EX-101.PRE 15559
9 EXTRACTED XBRL INSTANCE DOCUMENT lumo-20221129_htm.xml XML 10968
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 221436612
SIC: 2834 Pharmaceutical Preparations